Letter: An Update of Neuroanesthesia for Intraoperative Brain Mapping Craniotomy

In Reply: An Update of Neuroanesthesia for Intraoperative Brain Mapping Craniotomy

“…We thank the authors 1 for the great interest in our article 2 and bringing up the potential use of remimazolam, a newer benzodiazepine agent, in awake neurosurgical mapping procedures. Remimazolam has been recently approved in the United States, the European Union/European Economic Area/the United Kingdom, China, and South Korea for procedural sedation and in Japan and South Korea for general anesthesia.…”